Trial Profile
An open-label, multi-center, 3-treatment period, sequential study to evaluate the effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Apremilast (Primary) ; Methotrexate
- Indications Psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- 07 Dec 2015 New trial record